An integrated microfluidic chip for immunocapture, preconcentration and separation of β-amyloid peptides.

We present an integrated microfluidic chip for detection of β-amyloid (Aβ) peptides. Aβ peptides are major biomarkers for the diagnosis of Alzheimer's disease (AD) in its early stages. This microfluidic device consists of three main parts: (1) An immunocapture microcolumn based on self-assembled magnetic beads coated with antibodies specific to Aβ peptides, (2) a nano-porous membrane made of photopolymerized hydrogel for preconcentration, and (3) a microchip electrophoresis (MCE) channel with fluorescent detection. Sub-milliliter sample volume is either mixed off-chip with antibody coated magnetic beads and injected into the device or is injected into an already self-assembled column of magnetic beads in the microchannel. The captured peptides on the beads are then electrokinetically eluted and re-concentrated onto the nano-membrane in a few nano-liters. By integrating the nano-membrane, total assay time was reduced and also off-chip re-concentration or buffer exchange steps were not needed. Finally, the concentrated peptides in the chip are separated by electrophoresis in a polymer-based matrix. The device was applied to the capture and MCE analysis of differently truncated peptides Aβ (1-37, 1-39, 1-40, and 1-42) and was able to detect as low as 25 ng of synthetic Aβ peptides spiked in undiluted cerebrospinal fluid (CSF). The device was also tested with CSF samples from healthy donors. CSF samples were fluorescently labelled and pre-mixed with the magnetic beads and injected into the device. The results indicated that Aβ1-40, an important biomarker for distinguishing patients with frontotemporal lobe dementia from controls and AD patients, was detectable. Although the sensitivity of this device is not yet enough to detect all Aβ subtypes in CSF, this is the first report on an integrated or semi-integrated device for capturing and analyzing of differently truncated Aβ peptides. The method is less demanding and faster than the conventional Western blotting method currently used for research.

[1]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[2]  M. Chiari,et al.  Neutral polymers as coatings for high resolution electrophoretic separation of Aβ peptides on glass microchips. , 2014, The Analyst.

[3]  R. Dean,et al.  Validation and Clinical Utility of ELISA Methods for Quantification of Amyloid-β of Peptides in Cerebrospinal Fluid Specimens from Alzheimer’s Disease Studies. , 2015, Journal of Alzheimer's disease : JAD.

[4]  H. Karnes,et al.  Microfluidic capillary system for immunoaffinity separations of C-reactive protein in human serum and cerebrospinal fluid. , 2008, Analytical chemistry.

[5]  Mehmet Toner,et al.  Multifunctional Encoded Particles for High-Throughput Biomolecule Analysis , 2007, Science.

[6]  Lei Gu,et al.  Alzheimer's Aβ42 and Aβ40 peptides form interlaced amyloid fibrils , 2013, Journal of neurochemistry.

[7]  M. Hayes,et al.  Flow-based microimmunoassay. , 2001, Analytical chemistry.

[8]  M. Hennion,et al.  Online preconcentration using monoliths in electrochromatography capillary format and microchips. , 2007, Journal of separation science.

[9]  Jean-Louis Viovy,et al.  Development of a magnetic immunosorbent for on-chip preconcentration of amyloid β isoforms: Representatives of Alzheimer's disease biomarkers. , 2012, Biomicrofluidics.

[10]  J. Viovy,et al.  Epitope mapping of allergen ovalbumin using biofunctionalized magnetic beads packed in microfluidic channels The first step towards epitope-based vaccines. , 2008, Journal of chromatography. A.

[11]  Jean-Louis Viovy,et al.  Controlled proteolysis of normal and pathological prion protein in a microfluidic chip. , 2008, Lab on a chip.

[12]  P. Lewczuk,et al.  Neurochemical dementia diagnostics: State of the art and research perspectives , 2008, Proteomics.

[13]  Kevin D Dorfman,et al.  Quantitative microfluidic separation of DNA in self-assembled magnetic matrixes. , 2004, Analytical chemistry.

[14]  Martin A. M. Gijs,et al.  Quadrupolar magnetic actuation of superparamagnetic particles for enhanced microfluidic perfusion , 2009 .

[15]  N. Kaji,et al.  Dynamic coating using methylcellulose and polysorbate 20 for nondenaturing electrophoresis of proteins on plastic microchips , 2007, Electrophoresis.

[16]  R. Crooks,et al.  Transient effects on microchannel electrokinetic filtering with an ion-permselective membrane. , 2008, Analytical chemistry.

[17]  H. Girault,et al.  Magnetic core shell nanoparticles trapping in a microdevice generating high magnetic gradient. , 2011, Lab on a chip.

[18]  P. Scheltens,et al.  Decreased cerebrospinal fluid amyloid beta (1–40) levels in frontotemporal lobar degeneration , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[19]  R. Aebersold,et al.  Mass spectrometry-based proteomics , 2003, Nature.

[20]  D. Selkoe,et al.  Amyloid β-peptide is produced by cultured cells during normal metabolism , 1992, Nature.

[21]  Walter Kolch,et al.  Discovery of biomarkers in human urine and cerebrospinal fluid by capillary electrophoresis coupled to mass spectrometry: Towards new diagnostic and therapeutic approaches , 2005, Electrophoresis.

[22]  L. Ceriotti,et al.  New adsorbed coatings for capillary electrophoresis , 2000, Electrophoresis.

[23]  Jean-Michel Siaugue,et al.  Microchip integrating magnetic nanoparticles for allergy diagnosis. , 2011, Lab on a chip.

[24]  P. Scheltens,et al.  Quantification of amyloid-beta 40 in cerebrospinal fluid. , 2009, Journal of immunological methods.

[25]  Jean-Louis Viovy,et al.  Use of self assembled magnetic beads for on-chip protein digestion. , 2005, Lab on a chip.

[26]  Adam T Woolley,et al.  Affinity monolith preconcentrators for polymer microchip capillary electrophoresis , 2008, Electrophoresis.

[27]  S. Estus,et al.  Production of the Alzheimer amyloid beta protein by normal proteolytic processing. , 1992, Science.

[28]  Jean-Louis Viovy,et al.  Self-Assembled Magnetic Matrices for DNA Separation Chips , 2002, Science.

[29]  D. Selkoe,et al.  Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids , 1992, Nature.

[30]  J. Michael Ramsey,et al.  Effects of injection schemes and column geometry on the performance of microchip electrophoresis devices , 1994 .

[31]  J. Wiltfang,et al.  Microchip electrophoresis profiling of Aβ peptides in the cerebrospinal fluid of patients with Alzheimer's disease. , 2010, Analytical chemistry.

[32]  R. Crooks,et al.  The influence of membrane ion-permselectivity on electrokinetic concentration enrichment in membrane-based preconcentration units. , 2008, Lab on a chip.

[33]  N F de Rooij,et al.  Electrokinetically driven microfluidic chips with surface-modified chambers for heterogeneous immunoassays. , 2001, Analytical chemistry.

[34]  J. Kornhuber,et al.  Highly conserved and disease‐specific patterns of carboxyterminally truncated Aβ peptides 1–37/38/39 in addition to 1–40/42 in Alzheimer's disease and in patients with chronic neuroinflammation , 2002, Journal of neurochemistry.

[35]  Saeid Nahavandi,et al.  Microfluidic platforms for biomarker analysis. , 2014, Lab on a chip.

[36]  T. Morgan,et al.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Alejandro Cifuentes,et al.  On‐line capillary electrophoresis‐mass spectrometry for the analysis of biomolecules , 2004, Electrophoresis.

[38]  J. Hubbell,et al.  Characterization of permeability and network structure of interfacially photopolymerized poly(ethylene glycol) diacrylate hydrogels. , 1998, Biomaterials.

[39]  Adam T Woolley,et al.  Affinity monolith-integrated poly(methyl methacrylate) microchips for on-line protein extraction and capillary electrophoresis. , 2008, Analytical chemistry.

[40]  K. Blennow.  CSF biomarkers for Alzheimer’s disease: use in early diagnosis and evaluation of drug treatment , 2005, Expert review of molecular diagnostics.